1953
DOI: 10.3181/00379727-84-20621
|View full text |Cite
|
Sign up to set email alerts
|

Relationship of Pyridoxine and its Derivatives to the Mechanism of Action of Isoniazid.

Abstract: In most instances of metabolic antagonism the essential metabolite and the inhibitory agent have been similar in chemical structure. The structural appearance of isoniazid: lead to the speculation that its mode of action might represent interference with the utilization of nicotinamide or some other essential metabolite of similar structure. This report deals with the screening of certain vitamins, some of which are structurally similar to isoniazid, for possible isoniazid reversal.Materials and methods. The m… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
5
0

Year Published

1957
1957
2015
2015

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 27 publications
(5 citation statements)
references
References 3 publications
(4 reference statements)
0
5
0
Order By: Relevance
“…It became clear from the work of Biehl and Vilter (1954) that high doses of isoniazid (20 mg./kg./ day) regularly produced symptoms of neuritis in patients, that their excretion of vitamin B6 under isoniazid medication rose to three times the normal rate and that large doses of pyridoxine were fully protective against developing neuropathy. The action of isoniazid had already been shown to be competitive against the phosphorylation of pyridoxine and its inhibitory action upon microorganisms was competitively reversed, particularly by pyridoxamine and by pyridoxal (Boone and Woodward, 1953;Lichstein, 1955). The reason for the occurrence of only 40% incidence of neuritis in patients on a high daily dose of isoniazid became clear when it was shown by Biehl (1956; that, on the basis of finding a bimodal distribution of the percentage of administered isoniazid found free in the urine, patients could be divided into two clear groups, slow inactivators and rapid inactivators.…”
mentioning
confidence: 99%
“…It became clear from the work of Biehl and Vilter (1954) that high doses of isoniazid (20 mg./kg./ day) regularly produced symptoms of neuritis in patients, that their excretion of vitamin B6 under isoniazid medication rose to three times the normal rate and that large doses of pyridoxine were fully protective against developing neuropathy. The action of isoniazid had already been shown to be competitive against the phosphorylation of pyridoxine and its inhibitory action upon microorganisms was competitively reversed, particularly by pyridoxamine and by pyridoxal (Boone and Woodward, 1953;Lichstein, 1955). The reason for the occurrence of only 40% incidence of neuritis in patients on a high daily dose of isoniazid became clear when it was shown by Biehl (1956; that, on the basis of finding a bimodal distribution of the percentage of administered isoniazid found free in the urine, patients could be divided into two clear groups, slow inactivators and rapid inactivators.…”
mentioning
confidence: 99%
“…The mechanism of the inhibition of pyridoxal phosphate-dependent enzymes by hydrazides; especially isoniazid, has been widely discussed by many authors. I t has been suggested that the inhibition by isoniazid is due to competition between pyridoxal and isoniazid, for there is a structural resemblance between these two substances and the inhibition is reversed in many cases by pyridoxal (YONEDA et al 1952, YONEDA and ASANO 1953, BOONE and WOODWARD 1953. VILTER et al (1954) and DAVISON (1956) have suggested that the inhibition of these enzymes by hydrazine derivatives is due to the formation of hydrazonic compounds with pyridoxal.…”
Section: Discussionmentioning
confidence: 99%
“…Pope (1956) found that pyridoxal and pyridoxamine caused reversal of the antituberculous activity, but Oestreicher et al (1954) obtained reversal only with pyridoxal. Boone & Woodward (1953) and Ungar, Tomich, Parkin & Muggleton (1954) failed to detect reversal by either compound. Failure to obtain reversal of the antituberculous activity in vivo by concurrent admin-istration of vitamin B. in mice and guinea pigs has also been reported (Ungar et al 1954;Grunberg & Blencowe, 1955;Wasz-Hockert, McCune & Tompsett, 1956;Brun, Cayre & Viallier, 1954).…”
mentioning
confidence: 86%